Arttu Autio1,2, Jalmari Kettunen3, Tapio Nevalainen3,4,5, Bryn Kimura3, Mikko Hurme3,4. 1. Faculty of Medicine and Health Technology, Tampere University, Arvo Ylpön katu 34, 33520, Tampere, Finland. arttu.autio@tuni.fi. 2. Gerontology Research Center (GEREC), Tampere, Finland. arttu.autio@tuni.fi. 3. Faculty of Medicine and Health Technology, Tampere University, Arvo Ylpön katu 34, 33520, Tampere, Finland. 4. Gerontology Research Center (GEREC), Tampere, Finland. 5. Science Centre, Pirkanmaa Hospital District, Tampere, Finland.
Abstract
BACKGROUND: As we age, the functioning of the human immune system declines. The results of this are increases in morbidity and mortality associated with infectious diseases, cancer, cardiovascular disease, and neurodegenerative disease in elderly individuals, as well as a weakened vaccination response. The aging of the immune system is thought to affect and be affected by the human virome, the collection of all viruses present in an individual. Persistent viral infections, such as those caused by certain herpesviruses, can be present in an individual for long periods of time without any overt pathology, yet are associated with disease in states of compromised immune function. To better understand the effects on human health of such persistent viral infections, we must first understand how the human virome changes with age. We have now analyzed the composition of the whole blood virome of 317 individuals, 21-70 years old, using a metatranscriptomic approach. Use of RNA sequencing data allows for the unbiased detection of RNA viruses and active DNA viruses. RESULTS: The data obtained showed that Epstein-Barr virus (EBV) was the most frequently expressed virus, with other detected viruses being herpes simplex virus 1, human cytomegalovirus, torque teno viruses, and papillomaviruses. Of the 317 studied blood samples, 68 (21%) had EBV expression, whereas the other detected viruses were only detected in at most 6 samples (2%). We therefore focused on EBV in our further analyses. Frequency of EBV detection, relative EBV RNA abundance and the genetic diversity of EBV was not significantly different between age groups (21-59 and 60-70 years old). No significant correlation was seen between EBV RNA abundance and age. Deconvolution analysis revealed a significant difference in proportions of activated dendritic cells, macrophages M1, and activated mast cells between EBV expression positive and negative individuals. CONCLUSIONS: As it is likely that the EBV RNA quantified in this work is derived from reactivation of the latent EBV virus, these data suggest that age does not affect the rate of reactivation nor the genetic landscape of EBV. These findings offer new insight on the genetic diversity of a persistent EBV infection in the long-term.
BACKGROUND: As we age, the functioning of the human immune system declines. The results of this are increases in morbidity and mortality associated with infectious diseases, cancer, cardiovascular disease, and neurodegenerative disease in elderly individuals, as well as a weakened vaccination response. The aging of the immune system is thought to affect and be affected by the human virome, the collection of all viruses present in an individual. Persistent viral infections, such as those caused by certain herpesviruses, can be present in an individual for long periods of time without any overt pathology, yet are associated with disease in states of compromised immune function. To better understand the effects on human health of such persistent viral infections, we must first understand how the human virome changes with age. We have now analyzed the composition of the whole blood virome of 317 individuals, 21-70 years old, using a metatranscriptomic approach. Use of RNA sequencing data allows for the unbiased detection of RNA viruses and active DNA viruses. RESULTS: The data obtained showed that Epstein-Barr virus (EBV) was the most frequently expressed virus, with other detected viruses being herpes simplex virus 1, human cytomegalovirus, torque teno viruses, and papillomaviruses. Of the 317 studied blood samples, 68 (21%) had EBV expression, whereas the other detected viruses were only detected in at most 6 samples (2%). We therefore focused on EBV in our further analyses. Frequency of EBV detection, relative EBV RNA abundance and the genetic diversity of EBV was not significantly different between age groups (21-59 and 60-70 years old). No significant correlation was seen between EBV RNA abundance and age. Deconvolution analysis revealed a significant difference in proportions of activated dendritic cells, macrophages M1, and activated mast cells between EBV expression positive and negative individuals. CONCLUSIONS: As it is likely that the EBV RNA quantified in this work is derived from reactivation of the latent EBV virus, these data suggest that age does not affect the rate of reactivation nor the genetic landscape of EBV. These findings offer new insight on the genetic diversity of a persistent EBV infection in the long-term.
Authors: Eric R Weiss; Susanna L Lamers; Jennifer L Henderson; Alexandre Melnikov; Mohan Somasundaran; Manuel Garber; Liisa Selin; Chad Nusbaum; Katherine Luzuriaga Journal: J Virol Date: 2018-01-02 Impact factor: 5.103
Authors: Omer Coskun; Kenan Sener; Selim Kilic; Hakan Erdem; Halil Yaman; Ahmet Bulent Besirbellioglu; Hanefi Cem Gul; Can Polat Eyigun Journal: Clin Exp Med Date: 2009-09-25 Impact factor: 3.984
Authors: Henry H Balfour; Frangiscos Sifakis; Joseph A Sliman; Jennifer A Knight; David O Schmeling; William Thomas Journal: J Infect Dis Date: 2013-07-18 Impact factor: 5.226
Authors: Robertina Giacconi; Fabrizio Maggi; Lisa Macera; Pietro Giorgio Spezia; Mauro Pistello; Mauro Provinciali; Francesco Piacenza; Andrea Basso; Alexander Bürkle; María Moreno-Villanueva; Martijn E T Dollé; Eugène Jansen; Tilman Grune; Wolfgang Stuetz; Efstathios S Gonos; Christiane Schön; Jürgen Bernhardt; Beatrix Grubeck-Loebenstein; Ewa Sikora; Magdalena Dudkowska; Dorota Janiszewska; Olivier Toussaint; Florence Debacq-Chainiaux; Claudio Franceschi; Miriam Capri; Antti Hervonen; Mikko Hurme; Eline Slagboom; Nicolle Breusing; Eugenio Mocchegiani; Marco Malavolta Journal: J Gerontol A Biol Sci Med Sci Date: 2020-09-25 Impact factor: 6.053
Authors: Tamas Fulop; Anis Larbi; Gilles Dupuis; Aurélie Le Page; Eric H Frost; Alan A Cohen; Jacek M Witkowski; Claudio Franceschi Journal: Front Immunol Date: 2018-01-10 Impact factor: 7.561
Authors: Michelle H F Dias; Luiz F F Guimarães; Matheus G Barcelos; Eduardo U M Moreira; Maria F A do Nascimento; Taís N de Souza; Camilla V Pires; Talita A F Monteiro; Jaap M Middeldorp; Irene S Soares; Cor J F Fontes; Francis B Ntumngia; John H Adams; Flora S Kano; Luzia H Carvalho Journal: PLoS Negl Trop Dis Date: 2022-08-03